183 related articles for article (PubMed ID: 34843812)
41. Ventilator Weaning and Discontinuation Practices for Critically Ill Patients.
Burns KEA; Rizvi L; Cook DJ; Lebovic G; Dodek P; Villar J; Slutsky AS; Jones A; Kapadia FN; Gattas DJ; Epstein SK; Pelosi P; Kefala K; Meade MO;
JAMA; 2021 Mar; 325(12):1173-1184. PubMed ID: 33755077
[TBL] [Abstract][Full Text] [Related]
42. Comparison of 1,3-β-d-glucan with galactomannan in serum and bronchoalveolar fluid for the detection of Aspergillus species in immunosuppressed mechanical ventilated critically ill patients.
Lahmer T; Neuenhahn M; Held J; Rasch S; Schmid RM; Huber W
J Crit Care; 2016 Dec; 36():259-264. PubMed ID: 27475024
[TBL] [Abstract][Full Text] [Related]
43. Incidence, risk factors and mortality of invasive pulmonary aspergillosis in patients with influenza: A systematic review and meta-analysis.
Shi C; Shan Q; Xia J; Wang L; Wang L; Qiu L; Xie Y; Lin N; Wang L
Mycoses; 2022 Feb; 65(2):152-163. PubMed ID: 34882852
[TBL] [Abstract][Full Text] [Related]
44. Invasive pulmonary aspergillosis in critically ill patients with severe COVID-19 pneumonia: Results from the prospective AspCOVID-19 study.
Lahmer T; Kriescher S; Herner A; Rothe K; Spinner CD; Schneider J; Mayer U; Neuenhahn M; Hoffmann D; Geisler F; Heim M; Schneider G; Schmid RM; Huber W; Rasch S
PLoS One; 2021; 16(3):e0238825. PubMed ID: 33730058
[TBL] [Abstract][Full Text] [Related]
45. Isolation of Aspergillus in critically ill patients: a potential marker of poor outcome.
Khasawneh F; Mohamad T; Moughrabieh MK; Lai Z; Ager J; Soubani AO
J Crit Care; 2006 Dec; 21(4):322-7. PubMed ID: 17175418
[TBL] [Abstract][Full Text] [Related]
46. Glutamine dipeptide-supplemented parenteral nutrition improves the clinical outcomes of critically ill patients: A systematic evaluation of randomised controlled trials.
Stehle P; Ellger B; Kojic D; Feuersenger A; Schneid C; Stover J; Scheiner D; Westphal M
Clin Nutr ESPEN; 2017 Feb; 17():75-85. PubMed ID: 28361751
[TBL] [Abstract][Full Text] [Related]
47. [Respiratory infections caused by Aspergillus spp. in critically ill patients admitted to the intensive care units].
Álvarez Lerma F; Olaechea Astigarraga P; Palomar Martínez M; Rodríguez Carvajal M; Machado Casas JF; Jiménez Quintana MM; Esteve Urbano F; Ballesteros Herráez JC; Zavala Zegarra E;
Med Intensiva; 2015 Apr; 39(3):149-59. PubMed ID: 24713089
[TBL] [Abstract][Full Text] [Related]
48. Invasive pulmonary aspergillosis in critically ill patients with pneumonia due to COVID-19, influenza, and community-acquired pneumonia: A prospective observational study.
Ali SA; Jabeen K; Farooqi J; Niamatullah H; Siddiqui AF; Awan S; Akbar A; Irfan M
Curr Med Mycol; 2022 Jun; 8(2):16-24. PubMed ID: 36654789
[TBL] [Abstract][Full Text] [Related]
49. Clinical and Microbiological Characteristics of Culture-Positive, Influenza-Associated Pulmonary Aspergillosis: A Single-Center Study in Southern Taiwan, 2016-2019.
Wu CJ; Cia CT; Wang HC; Chen CW; Lin WC; Lee JC; Chen PS; Hsieh CC; Li WT; Su PL; Liao XM; Hsieh MI; Choi PC; Ko WC
J Fungi (Basel); 2022 Jan; 8(1):. PubMed ID: 35049989
[TBL] [Abstract][Full Text] [Related]
50. Risk factors and outcome of pulmonary aspergillosis in critically ill coronavirus disease 2019 patients-a multinational observational study by the European Confederation of Medical Mycology.
Prattes J; Wauters J; Giacobbe DR; Salmanton-García J; Maertens J; Bourgeois M; Reynders M; Rutsaert L; Van Regenmortel N; Lormans P; Feys S; Reisinger AC; Cornely OA; Lahmer T; Valerio M; Delhaes L; Jabeen K; Steinmann J; Chamula M; Bassetti M; Hatzl S; Rautemaa-Richardson R; Koehler P; Lagrou K; Hoenigl M;
Clin Microbiol Infect; 2022 Apr; 28(4):580-587. PubMed ID: 34454093
[TBL] [Abstract][Full Text] [Related]
51. Clinical Characteristics Between Survivors and Nonsurvivors of COVID-19 Patients Requiring Extracorporeal Membrane Oxygenation (ECMO) Support: A Systematic Review and Meta-Analysis.
Chong WH; Saha BK; Medarov BI
J Intensive Care Med; 2022 Mar; 37(3):304-318. PubMed ID: 34636697
[No Abstract] [Full Text] [Related]
52. Factors Affecting Mortality in Critically Ill Patients With Tuberculosis: A Systematic Review and Meta-Analysis.
Mishra S; Gala J; Chacko J
Crit Care Med; 2024 Jun; 52(6):e304-e313. PubMed ID: 38345418
[TBL] [Abstract][Full Text] [Related]
53. Timing of renal replacement therapy initiation for acute kidney injury in critically ill patients: a systematic review of randomized clinical trials with meta-analysis and trial sequential analysis.
Li X; Liu C; Mao Z; Li Q; Zhou F
Crit Care; 2021 Jan; 25(1):15. PubMed ID: 33407756
[TBL] [Abstract][Full Text] [Related]
54. Extracorporeal membrane oxygenation in severe influenza infection with respiratory failure: A systematic review and meta-analysis.
Sukhal S; Sethi J; Ganesh M; Villablanca PA; Malhotra AK; Ramakrishna H
Ann Card Anaesth; 2017; 20(1):14-21. PubMed ID: 28074789
[TBL] [Abstract][Full Text] [Related]
55. Aspergillosis: Emerging risk groups in critically ill patients.
Kluge S; Strauß R; Kochanek M; Weigand MA; Rohde H; Lahmer T
Med Mycol; 2021 Dec; 60(1):. PubMed ID: 34677613
[TBL] [Abstract][Full Text] [Related]
56. Epidemiology of invasive aspergillosis in critically ill patients: clinical presentation, underlying conditions, and outcomes.
Taccone FS; Van den Abeele AM; Bulpa P; Misset B; Meersseman W; Cardoso T; Paiva JA; Blasco-Navalpotro M; De Laere E; Dimopoulos G; Rello J; Vogelaers D; Blot SI;
Crit Care; 2015 Jan; 19(1):7. PubMed ID: 25928694
[TBL] [Abstract][Full Text] [Related]
57. [Research status of severe influenza-associated invasive pulmonary aspergillosis in intensive care unit].
Zhang YF; Huang LN; Zhan QY
Zhonghua Jie He He Hu Xi Za Zhi; 2021 Jul; 44(7):651-655. PubMed ID: 34256451
[TBL] [Abstract][Full Text] [Related]
58. International survey on influenza-associated pulmonary aspergillosis (IAPA) in intensive care units: responses suggest low awareness and potential underdiagnosis outside Europe.
Thevissen K; Jacobs C; Holtappels M; Toda M; Verweij P; Wauters J
Crit Care; 2020 Mar; 24(1):84. PubMed ID: 32160910
[No Abstract] [Full Text] [Related]
59. Diagnostic value of galactomannan test in non-immunocompromised critically ill patients with influenza-associated aspergillosis: data from three consecutive influenza seasons.
Huang L; Zhang Y; Hua L; Zhan Q
Eur J Clin Microbiol Infect Dis; 2021 Sep; 40(9):1899-1907. PubMed ID: 33837879
[TBL] [Abstract][Full Text] [Related]
60. [The diagnostic performance of galactomannan detection in invasive pulmonary aspergillosis with severe and critically ill influenza].
Lin PC; Zeng JH; Su SS; Zhou Y; Chen JJ; Chen CS; Li YP
Zhonghua Yi Xue Za Zhi; 2021 Apr; 101(15):1050-1056. PubMed ID: 33878831
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
